Ben Chien is the founder of Foresee pharma. Foresee pharma has raised $42M in total funding. Latest round: IPO. Based in Taipei, Taiwan.
Ben Chien is the Founder, Chairman & CEO of Foresee Pharmaceuticals, a company that spun off from QPS Holdings, LLC's research division in 2011. Foresee Pharmaceuticals has licensed out its lead clinical product, CAMCEVI™, for US$420 million, and the drug has received US FDA approval. The company specializes in an innovative drug delivery platform, particularly its stabilized injectable formulation (SIF) technology, which aims to simplify the administration of existing products and develop new innovative drugs.
Full founder directory · Investor directory · Company funding database · Fundraising library